INMODE LTD (INMD)
IL0011595993 - Common Stock
INMODE LTD
NASDAQ:INMD (12/23/2024, 7:09:19 PM)
After market: 17.19 +0.24 (+1.42%)16.95
-0.13 (-0.76%)
Company Profile
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Company Info
INMODE LTD
Tavor Building, Sha'ar Yokneam, Pob 533
Yokneam 2069200
P: 97249097470
CEO: Moshe Mizrahy
Employees: 581
Website: https://inmodemd.com/
INMD News
18 days ago - Market News VideoINMD Crosses Below Key Moving Average Level2 months ago - Market News VideoINMD Crosses Above Key Moving Average Level2 months ago - InMode Ltd.InMode to Present at Upcoming Investor Conferences/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following...
2 months ago - The Motley FoolInMode (INMD) Q3 2024 Earnings Call TranscriptINMD earnings call for the period ending September 30, 2024.
2 months ago - InMode Ltd.InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial...
2 months ago - InMode Ltd.InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories/PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S....
INMD Twits
Here you can normally see the latest stock twits on INMD, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
